Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-4-28
pubmed:abstractText
Mutations in the genes encoding the subunit polypeptides of the alpha6beta4 integrin (ITGA6 and ITGB4, respectively) have been previously demonstrated in patients with a lethal form of epidermolysis bullosa with congenital pyloric atresia (OMIM #226730). In this study, we demonstrate for the first time ITGB4 mutations in nonlethal phenotype of epidermolysis bullosa with congenital pyloric atresia. Specifically, the proband was shown to be a compound heterozygote for a missense mutation (L156P) and a nonsense mutation (R554X). The leucine substitution by proline was shown to affect a residue, which was precisely conserved in different human, rodent, and drosophila integrin-beta polypeptides, and consequently disrupts the alpha-helix formation of the polypeptide segment as determined by Garnier alpha-helicity plot. The nonsense mutation in another allele was accompanied by undetectable levels of the corresponding mRNA transcript, as determined by reverse transcription-polymerase chain reaction. The presence of a missense mutation, when combined with a premature termination codon mutation, may explain the milder blistering tendency of the skin in this patient.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-1500432, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-1569120, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-1918072, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-1959558, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-1999509, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-2083230, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-2211615, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-2311578, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-2365683, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-2958481, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-3028646, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-3494014, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-6161971, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-642007, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-7545057, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-7593178, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-8076521, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-8234293, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-8257791, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-8712842, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-8832392, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-8983017, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9074510, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9108036, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9158140, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9182827, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9185503, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9194858, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9199555, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9284109, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9358473, http://linkedlifedata.com/resource/pubmed/commentcorrection/9546354-9422533
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
152
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
935-41
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9546354-Amino Acid Sequence, pubmed-meshheading:9546354-Antigens, CD, pubmed-meshheading:9546354-Blotting, Western, pubmed-meshheading:9546354-Epidermolysis Bullosa, pubmed-meshheading:9546354-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:9546354-Heterozygote, pubmed-meshheading:9546354-Humans, pubmed-meshheading:9546354-Immunohistochemistry, pubmed-meshheading:9546354-Infant, pubmed-meshheading:9546354-Integrin beta4, pubmed-meshheading:9546354-Integrins, pubmed-meshheading:9546354-Intestinal Atresia, pubmed-meshheading:9546354-Male, pubmed-meshheading:9546354-Molecular Sequence Data, pubmed-meshheading:9546354-Mutation, pubmed-meshheading:9546354-Pedigree, pubmed-meshheading:9546354-Polymerase Chain Reaction, pubmed-meshheading:9546354-Pylorus, pubmed-meshheading:9546354-Transcription, Genetic
pubmed:year
1998
pubmed:articleTitle
Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the beta4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia.
pubmed:affiliation
Department of Dermatology and Cutaneous Biology, Jefferson Medical College, and Jefferson Institute of Molecular Medicine, Philadelphia, Pennsylvania 19107, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Case Reports, Research Support, Non-U.S. Gov't